Functional Properties of Human Intestinal Mast Cells Cultured in a New Culture System: Enhancement of IgE Receptor-Dependent Mediator Release and Response to Stem Cell Factor

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5560-5567

  Bischoff, Stephan C ^a   Schwengberg, Silke ^a   Raab, Rudolf ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; INTERLEUKIN 3; MONOCLONAL ANTIBODY; STEM CELL FACTOR;

ARTICLE; CELL DIVISION; CELL SURVIVAL; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HISTAMINE RELEASE; HUMAN; IMMUNOLOGY; INTESTINE; MAST CELL; METABOLISM; METHODOLOGY; TIME;

ANTIBODIES, MONOCLONAL; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HISTAMINE; HISTAMINE RELEASE; HUMANS; INTERLEUKIN-3; INTESTINES; MAST CELLS; STEM CELL FACTOR; TIME FACTORS;

EID: 0031298115     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gordon, J. R., P. R. Burd, and S. J. Galli. 1990. Mast cells as a source of multifunctional cytokines. Immunol. Today 11:458.
2. Mécheri, S., and B. David. 1997. Unravelling the mast cell dilemma: culprit or victim of its generosity? Immunol. Today 18:212.
3. Ohkawara, Y., K. Yamauchi, Y. Tanno, G. Tamura, H. Ohtani, H. Nagura, K. Ohkuda, and T. Takishima. 1992. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor α in sensitized lung tissue after IgE receptor triggering. Am. J. Respir. Cell Mol. Biol. 7:385.
4. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukins (IL)-4, -5. -6, and TNF-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471.
5. Okayama, Y., C. Petit-Frère, O. Kassel, A. Semper, D. Quint, M. J. Tunon-de Lara, P. Bradding, S. T. Holgate, and M. K. Church. 1995. IgE-dependent expression of mRNA of IL-4 and IL-5 in human lung mast cells. J. Immunol. 155:1796.
6. Valent, P., J. Besemer, C. Sillaber, J. R. Butterfield, R. Eher, O. Majdic, K. Kishi, W. Klepetko, F. Eckersberger, K. Lechner, and P. Bettelheim. 1990. Failure to detect IL-3-binding sites on human mast cells. J. Immunol. 145:1432.
7. Galli, S. J., K. M. Zsebo, and E. N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55:1.
8. Bischoff, S. C., and C. A. Dahinden. 1992. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175:237.
9. Columbo, M., E. M. Horowitz, L. M. Botana, D. W. MacGlashan, Jr., B. S. Bochner, S. Gillis, K. M. Zsebo, S. J. Galli, and L. M. Lichtenstein. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149:599.
10. Sperr, W. R., K. Czerwenka, G. Mundigler, M. R. Müller, H. Semper, G. Klappacher, H. D. Glogar, K. Lechner, and P. Valent. 1993. Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. Int. Arch. Allergy Immunol. 102:170.
11. Bischoff, S. C., S. Schwengberg, K. Wordelmann, A. Weimann, R. Raab, and M. P. Manns. 1996. Effect of c-kit ligand on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 38:104.
12. Furitsu, T., H. Saito, A. M. Dvorak, L. B. Schwartz, A. M. Irani, J. F. Burdick, K. Ishizaka, and T. Ishizaka. 1989. Development of human mast cells in vitro. Proc. Natl. Acad. Sci. USA 86:10039.
13. Mitsui, H., T. Furitsu, A. M. Dvorak, A. M. Irani, L. B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K. M. Zsebo, S. Gillis, and T. Ishizaka. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl. Acad. Sci. USA 90:735.
14. Valent, P., E. Spanblöchl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long-term culture. Blood 80:2237.
15. Irani, A. M., G. Nilsson, U. Miettinen, S. S. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009.
16. Levi-Schaffer, F., K. F. Austen, J. P. Caulfield, A. Hein, P. M. Gravallese, and R. L. Stevens. 1987. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes. J. Immunol. 139:494.
17. Fox, C. C., A. M. Dvorak, S. P. Peters, A. Kagey-Sobotka, and L. M. Lichtenstein. 1985. Isolation and characterization of human intestinal mucosal mast cells. J. Immunol. 135:483.
18. Befus, A. D., N. Dyck, R. Goodacre, and J. Bienenstock. 1987. Mast cells from the human intestinal lamina propria: isolation, histochemical subtypes, and functional characterization. J. Immunol. 138:2604.
19. Lowman, M. A., P. H. Rees, R. C. Benyon, and M. K. Church. 1988. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J. Allergy Clin. Immunol. 81:590.
20. Schulman, E. S., R. B. Pollack, T. J. Post, and S. P. Peters. 1990. Histochemical heterogeneity of dispersed human lung mast cells. J. Immunol. 144:4195.
21. Craig, S. S., and L. B. Schwartz. 1988. Tryptase and chymase, markers of distinct types of human mast cells. Immunol. Res. 8:130.
22. Weidner, N., and K. F. Austen. 1993. Heterogeneity of mast cells at multiple body sites. Pathol. Res. Pract. 189:156.
23. Riske, F., J. Hakimi, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Lin, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (Fc∈RI): analysis of functional domains of the α subunit with monoclonal antibodies. J. Biol. Chem. 266:11245.
24. Lerner, N. B., K. H. Nocka, S. R. Cole, F. Qiu, A. Strife, L. K. Ashman, and P. Besmer. 1991. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876.
25. Okayama, Y., T. C. Hunt, O. Kassel, L. K. Ashman, and M. K. Church. 1994. Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells. J. Immunol. Methods 169:153.
26. Bischoff, S. C., J. Wedemeyer, A. Herrmann, P. N. Meier, C. Trautwein, Y. Cetin, H. Maschek, M. Stolte, M. Gebel, and M. P. Manns. 1996. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28:1.
27. Bischoff, S. C., and C. A. Dahinden. 1992. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79:2662.
28. Ishizaka, T., H. Mitsui, M. Yanagida, T. Miura, and A. M. Dvorak. 1993. Development of human mast cells from their progenitors. Curr. Opin. Immunol. 5:937.
29. Schulman, E. S., T. J. Post, P. M. Henson, and P. C. Giclas. 1988. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J. Clin. Invest. 81:918.
30. Lawrence, I. D., J. A. Warner, V. L. Cohan, W. C. Hubbard, A. Kagey-Sobotka, and L. M. Lichtenstein. 1987. Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J. Immunol. 139:3062.
31. Sillaber, C., H. Strobl, D. Bevec, L. K. Ashman, J. H. Butterfield, K. Lechner, D. Maurer, P. Bettelheim, and P. Valent. 1991. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J. Immunol. 147:4224.
32. Yanagida, M., H. Fukamachi, K. Ohgami, T. Kuwaki, H. Ishii, H. Uzumaki, K. Amano, T. Tokiwa, H. Mitsui, H. Saito, Y. Ikura, T. Ishizaka, and T. Nakahata. 1995. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705.
33. Irani, A. M., S. S. Craig, G. DeBlois, C. O. Elson, N. O. Schlechter, and L. B. Schwartz. 1987. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J. Immunol. 138:4381.
34. Taylor, A. M., S. J. Galli, and J. W. Coleman. 1995. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem cell factor with other mast cell-activating agents. Immunology 86:427.
35. Fox, C. C., A. J. Lazenby, W. C. Moore, J. H. Yardley, T. M. Bayless, and L. M. Lichtenstein. 1990. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99:119.
36. Knutson, L., Ö. Ahrenstedt, B. Odling, and R. Hällgren. 1990. The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 98:849.
37. Lavö, B., L. Knutson, L. Lööf, B. Odlind, P. Venge, and R. Hällgren. 1989. Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am. J. Med. 87:655.